Who owns CLYM?
Institutional ownership of Climb Bio Inc. from Form 13F, Q2 2026
109 institutional managers reported holding Climb Bio Inc. (CLYM) in Form 13F filings for Q2 2026, with 56,329,704 shares worth $734M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 24,040,535 shares (+74.5%). 52 opened new positions and 22 sold out.
- Funds holding
- 109
- Value held
- $734M
- New / sold out
- 52 / 22
- Net shares, same filers
- +74.5%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of CLYM
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Ra Capital Management, L.p. | $147M | 20.1% | 11,300,939 | Unchanged |
| FMR LLC | $88.5M | 12.1% | 6,790,364 | Added |
| UBS Group AG | $44.4M | 6.0% | 3,404,866 | Added |
| Braidwell LP | $36.5M | 5.0% | 2,797,375 | Added |
| Adage Capital Partners GP, L.l.c. | $32.7M | 4.4% | 2,506,000 | New |
| BlackRock, Inc. | $30.7M | 4.2% | 2,354,872 | Added |
| Price T Rowe Associates Inc | $27.7M | 3.8% | 2,127,281 | Added |
| Cormorant Asset Management, LP | $27.5M | 3.7% | 2,106,000 | New |
| Frontier Capital Management Co LLC | $25.3M | 3.4% | 1,939,019 | New |
| Vanguard Capital Management LLC | $22.2M | 3.0% | 1,698,654 | Added |
| Woodline Partners LP | $20.6M | 2.8% | 1,582,291 | New |
| Citadel Advisors LLC | $16.9M | 2.3% | 1,297,972 | Added |
| Redmile Group, LLC | $16.0M | 2.2% | 1,226,330 | New |
| Great Point Partners LLC | $13.0M | 1.8% | 1,000,000 | Trimmed |
| Affinity Asset Advisors, LLC | $12.7M | 1.7% | 972,000 | Added |
| Millennium Management LLC | $11.8M | 1.6% | 908,198 | Trimmed |
| ADAR1 Capital Management, LLC | $10.7M | 1.5% | 822,649 | Added |
| Driehaus Capital Management LLC | $10.3M | 1.4% | 790,000 | Added |
| Geode Capital Management, LLC | $10.2M | 1.4% | 782,199 | Added |
| Stempoint Capital LP | $9.7M | 1.3% | 742,745 | New |
| State Street Corp | $9.0M | 1.2% | 686,772 | Added |
| Ameriprise Financial Inc | $8.6M | 1.2% | 657,971 | New |
| Parkman Healthcare Partners LLC | $7.3M | 1.0% | 563,484 | New |
| Superstring Capital Management LP | $6.8M | 0.9% | 521,082 | Added |
| Sphera Funds Management LTD. | $6.3M | 0.9% | 483,747 | Added |
Share of 13F holdings is each fund's shares as a share of the 56,329,704 CLYM shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- FMR LLC Added+$88.5M
- UBS Group AG Added+$43.3M
- Adage Capital Partners GP, L.l.c. New+$32.7M
- Cormorant Asset Management, LP New+$27.5M
- BlackRock, Inc. Added+$25.5M
- Frontier Capital Management Co LLC New+$25.3M
- Woodline Partners LP New+$20.6M
- Braidwell LP Added+$16.5M
- Redmile Group, LLC New+$16.0M
- Citadel Advisors LLC Added+$12.4M
Biggest sellers in Q2 2026
- MPM Bioimpact LLC Sold out-$17.8M
- Kynam Capital Management, LP Sold out-$6.9M
- Marshall Wace, LLP Sold out-$5.3M
- Millennium Management LLC Trimmed-$4.8M
- Silverarc Capital Management, LLC Sold out-$4.7M
- Susquehanna International Group, LLP Trimmed-$4.7M
- Great Point Partners LLC Trimmed-$4.4M
- Two Sigma Investments, LP Trimmed-$2.1M
- Diadema Partners LP Sold out-$2.0M
- Longaeva Partners L.P. Sold out-$1.5M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $416M and sold $64.1M; 32 added and 18 trimmed.
Schedule 13D and 13G filings on CLYM
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-10-28Flynn James E SCHEDULE 13G filed by Climb Bio Inc.Schedule 13G
- 2026-10-27BlackRock, Inc. SCHEDULE 13G filed by Climb Bio Inc.Schedule 13G
- 2026-07-08FMR LLC SCHEDULE 13G filed by Climb Bio Inc.Schedule 13G
- 2026-02-17MPM BioImpact LLC SCHEDULE 13G filed by Climb Bio Inc.Schedule 13G
- 2025-09-18Pontifax Management 4 G.P. (2015) Ltd. SCHEDULE 13G filed by Climb Bio Inc.Schedule 13G
Questions about CLYM ownership
- Who owns CLYM stock?
- 109 institutional investment managers reported CLYM positions in their Form 13F filings for Q2 2026, holding 56,329,704 shares worth $734M in total. Ra Capital Management, L.p. reported the largest position.
- Are funds buying or selling CLYM?
- In Q2 2026, 52 managers opened new CLYM positions, 32 added, 18 trimmed and 22 sold out. Managers that filed in both quarters added a net 24,040,535 shares.
- How current is this CLYM institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to CLYM by CUSIP. Options are left out. CLYM news and filings · CLYM insider trades · Top funds